Wellthy is a digital therapeutics company focused on improving patient health through the intersection of technology and clinical outcomes.
Wellthy Therapeutics designs and deploys clinically validated behavioral interventions for chronic disease management, and are pioneering Digital Therapeutics, an entirely new category of medicine to address the chronic health epidemic in South Asia at scale.
Wellthy Therapeutics was founded in 2015 by Abhishek Shah, Aradh Pillai, and Prayat Shah. The company is headquartered in Mumbai, Maharashtra, India.
Wellthy designs clinically validated behavioral interventions to help people change their behaviors and reduce their risk of chronic disease.
Wellthy, powered by artificial intelligence, its disease management platform is specially designed to address these gaps. They play the role of an on-demand nutritionist, educator, fitness coach and counsellor, enabling patients to develop the skills they need to prevent, manage and even reverse their chronic conditions.
Wellthy acts as a digital pill for patients, and a data aggregator and decision support system for all stakeholders in the health-care ecosystem, including private and public health systems, physicians, insurers, pharmaceutical and medical technology companies and governments.
Wellthy is backed by Saama Capital, BEENEXT, Currae Healthtech, Cipla and others. The company raised $4M in pre Series A round on Apr 13, 2020. This brings Wellthy's total funding to $7.6M to date.